Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating XW003 versus placebo in patients with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• XW003

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: T2DM, Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED